Clinical Trial Update: CGRP-induced Migraine Attacks in Patients Who Have Tried Anti-CGRP Monoclonal Antibody Treatment [NA]

View source ↗

Summary

A clinical trial update examining CGRP-induced migraine attacks in patients who have previously been treated with anti-CGRP monoclonal antibodies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Snippet

Sponsor: Danish Headache Center | Conditions: Migraine | NA | Status: UNKNOWN